FDA Cardiovascular and Renal Drugs Advisory Committee Meeting on CV Therapeutics’ Ranexa (Ranolazine) December 2, 2003 Filed under: Trends-in-Medicine
FDA Panel Recommends Appoval of Two New Cosmetic Fillers: Restylane and Hylaform December 2, 2003 Filed under: Trends-in-Medicine